EUVIMEDEUVIMED entdecken
Open Access

CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer

Yu-Zhao Wang, Yu-Chen Qian, Wen-Jie Yang, Lei-Hong Ye, Guo-Dong Guo, Wei Lv, Meng-Xi Huan, Xiao-Yu Feng, Ke Wang, Zhao Yang, Yang Gao, Lei Li und 1 weitere

Asian Journal of Andrology · 2023-03 · 25 (2) · 152-157

DOI: 10.4103/aja202287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Andrology, online erschienen am 10.01.2023. Verfasst von Yu-Zhao Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: Von Hippel-Lindau Tumor Suppressor Protein, Prostatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromodomain-helicase-DNA-binding protein 1 ( CHD1 ) deletion is among the most common mutations in prostate cancer (PCa), but its role remains unclear. In this study, RNA sequencing was conducted in PCa cells after clustered regularly interspaced palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9)-based CHD1 knockout. Gene set enrichment analysis (GSEA) indicated upregulation of hypoxia-related pathways. A subsequent study confirmed that CHD1 deletion significantly upregulated hypoxia-inducible factor 1α (HIF1α) expression. Mechanistic investigation revealed that CHD1 deletion upregulated HIF1α by transcriptionally downregulating prolyl hydroxylase domain protein 2 (PHD2), a prolyl hydroxylase catalyzing the hydroxylation of HIF1α and thus promoting its degradation by the E3 ligase von Hippel–Lindau tumor suppressor (VHL). Functional analysis showed that CHD1 deletion promoted angiogenesis and glycolysis, possibly through HIF1α target genes. Taken together, these findings indicate that CHD1 deletion enhances HIF1α expression through PHD2 downregulation and therefore promotes angiogenesis and metabolic reprogramming in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Von Hippel-Lindau Tumor Suppressor ProteinProstatic NeoplasmsMaleHumansDNA-Binding ProteinsProlyl HydroxylasesHypoxiaGlycolysisHypoxia-Inducible Factor 1, alpha SubunitCell Line, TumorDNA Helicases

Stichwörter der Autor:innen

CHD1HIF1αangiogenesismetabolismprostate cancer

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinDNA-Binding ProteinsProlyl HydroxylasesHypoxia-Inducible Factor 1, alpha SubunitCHD1 protein, humanDNA Helicases

Autor:innen und Institutionen

  • Department of Urology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Oncology Research Laboratory, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an 710061, China.

Zitieren

APA

Wang, Y. Z., Qian, Y. C., Yang, W. J., Ye, L. H., Guo, G. D., Lv, W., Huan, M. X., Feng, X. Y., Wang, K., Yang, Z., Gao, Y., Li, L., & Chen, Y. L. (2023). CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer. Asian Journal of Andrology, 25(2), 152-157. https://doi.org/10.4103/aja202287

Vancouver

Wang YZ, Qian YC, Yang WJ, Ye LH, Guo GD, Lv W, et al. CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer. Asian Journal of Andrology. 2023;25(2):152-157. doi:10.4103/aja202287

BibTeX
@article{Wang2023,
  author = {Wang, Yu-Zhao and Qian, Yu-Chen and Yang, Wen-Jie and Ye, Lei-Hong and Guo, Guo-Dong and Lv, Wei and Huan, Meng-Xi and Feng, Xiao-Yu and Wang, Ke and Yang, Zhao and Gao, Yang and Li, Lei and Chen, Yu-Le},
  title = {CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer},
  journal = {Asian Journal of Andrology},
  year = {2023},
  volume = {25},
  number = {2},
  pages = {152--157},
  doi = {10.4103/aja202287}
}
Kostenlos starten →